DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Inaperisone
Inaperisone
(12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 De Juan Et Al
(12) Patent Application Publication (10) Pub. No.: US 2004/0224012 A1 Suvanprakorn Et Al
)&F1y3x PHARMACEUTICAL APPENDIX to THE
Pharmaceuticals Appendix
Marrakesh Agreement Establishing the World Trade Organization
Tolperisone: a Typical Representative of a Class of Centrally Acting Muscle Relaxants with Less Sedative Side Effects
Customs Tariff - Schedule
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
WO 2007/061529 Al
(12) Patent Application Publication (10) Pub. No.: US 2003/0068365A1 Suvanprakorn Et Al
Fatal Tolperisone Poisoning: Autopsy and Toxicology findings in Three Suicide Cases
(12) Patent Application Publication (10) Pub. No.: US 2007/0065463 A1 Aung-Din (43) Pub
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Marrakesh Agreement Establishing the World Trade Organization
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Pharmaabkommen A1 E
Customs Tariff - Schedule Xxi - 1
Eperisone-Induced Anaphylaxis: Pharmacovigilance Data and Results of Allergy Testing
Top View
Sándor Farkas, MD
Harmonized Tariff Schedule of the United States (2006) (Rev
Immediate Allergic Reaction to Thiocolchicoside Confirmed by Skin Testing and Basophil Activation Test: a Case Report and Literature Review
Pharmaceutical Appendix to the Harmonized Tariff Schedule
(12) United States Patent (10) Patent No.: US 8,883,830 B2 Aung-Din (45) Date of Patent: *Nov
Basic Aspects of the Pharmacodynamics of Tolperisone, a Widely Applicable Centrally Acting Muscle Relaxant
Schedule Clxxiii - European Union
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri